title: [The chemotherapeutic use of antidiabetics. Sulfonylurea compounds and glinides].
authors.affiliation: Stoffwechselforschung Boehringer Ingelheim Pharma KG, 88397 Biberach. michael.mark@bc.boehringer-ingelheim.com
authors.forename: Michael
authors.initials: M
authors.lastname: Mark
mesh_terms: D000818:Animals; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D007328:Insulin / Q000378:metabolism; D010179:Pancreas / Q000187:drug effects / Q000378:metabolism; D013453:Sulfonylurea Compounds / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin; D013453:Sulfonylurea Compounds
vernacular_title: Vom Chemotherapeutikum zum Antidiabetikum. Sulfonylharnstoffe und Glinide.